Clinical Trials Directory

Trials / Completed

CompletedNCT02103400

Physical Training Program in Patients Hospitalized for Community-acquired Pneumonia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Nove de Julho · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Hospitalized patients with community-acquired pneumonia (CAP) have reduced functional capacity, peripheral muscle strength and quality of life. Despite the high incidence and severity has not yet been demonstrated whether a physical training program can change these outcomes. Objectives: To evaluate the effects of an exercise training program in patients hospitalized for CAP, to compare this effects with traditional physical therapy and assess whether the inflammatory markers correlate with the functional status of the patient and type of treatment. Methods: A controlled, prospective, randomized clinical trial. Patients hospitalized for CAP, adults, conscious, hemodynamically stable and independent to walk will be studied. In the first day, a medical history, measured dyspnea, incremental shuttle walk test, Glittre test, measurement of peripheral muscle strength, spirometry, and the application of quality of life questionnaire Shor Form 36 will be held. The measurement of inflammatory markers (C-reactive protein and tumor necrosis factor) will also be held. Patients will be randomized into two groups: one will perform a program of physical training (stretching, active resistance exercises and aerobic exercises) and the other group held the traditional physical therapy (bronchial hygiene, breathing exercises and walking) for eight days. On the tenth day the same assessment will be carried out initially described.

Conditions

Interventions

TypeNameDescription
OTHERExperimental groupExercise Training Group
OTHERControl groupExercise control group

Timeline

Start date
2014-03-01
Primary completion
2014-11-01
Completion
2015-02-01
First posted
2014-04-03
Last updated
2016-03-31

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02103400. Inclusion in this directory is not an endorsement.